Roche (RHHBY) announced the FDA approval of a label expansion into biliary tract cancer, or BTC, for the Pathway anti-HER2/neu Rabbit ...

The Knicks’ mile-high defensive woes won’t get any easier Monday night, when they will face potential triple-crown winner ...

Tesla’s Model 3 ranked last in a German reliability study of newer cars for the second year. The report found a high ...

Zanidatamab is a bispecific antibody that binds to 2 non-overlapping extracellular epitopes of the HER2 receptor.

Los Angeles Lakers rookie small forward, Dalton Knecht, is making a very early Rookie of the Year case with his recent performance.

The Food and Drug Administration granted accelerated approval to zanidatamab-hrii, or Ziihera from Jazz Pharmaceuticals (JAZZ), Inc., a ...

Rookie Dalton Knecht is making waves for Lakers, combining sharpshooting with impactful performances to fuel the team's early ...

The new drug, Jazz Pharmaceuticals’ zanidatamab, has won an FDA accelerated approval for adults with previously treated ...

Jazz Pharmaceuticals (JAZZ) stock and Zymeworks (ZYME) stock gain as FDA clears their cancer therapy Ziihera. Read more here.

They began an early season test last night (Wednesday), beginning a five-game road trip by facing the Phoenix Suns.

Jazz Pharmaceuticals plc (NASDAQ ... unresectable or metastatic HER2-positive (IHC 3+) biliary tract cancer (BTC), as detected by an FDA-approved test. This approval is based on compelling data from ...

NEW YORK – The US Food and Drug Administration on Wednesday granted accelerated approval to Jazz Pharmaceuticals' Ziihera (zanidatamab ... scores of 3+, according to an FDA-approved test. The approval ...